Rinvoq (upadacitinib)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Rinvoq (upadacitinib), covering 2025-02-10 to 2025-02-10. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Upadacitinib in Pediatric Participants With Severe Atopic Dermatitis [Phase 1]